Moscow City Oncology Hospital №62
In research, Moscow City Oncology Hospital №62 stands highest in Medicine (#9,341 of 10,443 worldwide) and Health Sciences (#11,128 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 16.4× its share of world research.
- World rank, 2022–2025
- #25,687 of 28,054 · #37,702 all time
- Rank in Russia
- #867 of 1,062
- Research works
- 304 ▲ 146% vs 2013–17
- Citations
- 3.9k 12.8 per fractional work
- Top-10% rate
- 2.4% record average 16.5%
- Open access
- 56% world 28%
What is Moscow City Oncology Hospital №62 known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #9,341 of 10,443 | 2.3% | 98 | #14345 | |
| Health SciencesDomain | #11,128 of 11,982 | 2.2% | 102 | #17464 |
Each strip is that field’s whole ranked pool, with the notch where Moscow City Oncology Hospital №62 sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Moscow City Oncology Hospital №62 specialise in?
Where its research is concentrated relative to its size: Oncology takes 16.4× the share of its output that it takes of world research.
- OncologySubfield · 23.0 works16×
- Pulmonary and Respiratory MedicineSubfield · 23.2 works12×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.1×. Every wedge is a field page.
- Medicine 4.1×
- Dentistry 2.3×
- Immunology and Microbiology 2.1×
- Veterinary 2.0×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Health Professions 0.5×
- Nursing 0.5×
- Economics, Econometrics and Finance 0.4×
- Neuroscience 0.4×
- Physics and Astronomy 0.3×
- Psychology 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Chemistry 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
- Materials Science 0.0×
- Business, Management and Accounting 0.0×
- Environmental Science 0.0×
Who are the top researchers at Moscow City Oncology Hospital №62?
Ranked on the composite score, Daniil Stroyakovskiy, Dobrovol'skiĭ and Н. А. Савелов lead among researchers whose main affiliation is Moscow City Oncology Hospital №62.
- 1 Daniil Stroyakovskiy Russia · #101,996 worldwide 232 citations · 32 works
- 2 Dobrovol'skiĭ Russia · #827,262 worldwide 2 citations · 26 works
- 3 Н. А. Савелов Russia · #1,375,173 worldwide 16 citations · 15 works
- 4 Ирина Демидова Russia · #1,396,122 worldwide 1 citations · 20 works
- 5 Korytnikov Ki Russia · #1,431,664 worldwide 0 citations · 17 works
Which keywords describe research at Moscow City Oncology Hospital №62?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Prognostic Factors, Clinical Practice Guidelines, Clinical Trials, Treatment, Molecular Characterization and Metastasis.
- Hepatocellular Carcinoma
- Ovarian Cancer
- Adjuvant Therapy
- Immune Checkpoint Blockade
- Molecular Profiling
- Renal Cell Carcinoma
- Survival
- Clinical Guidelines
- Management
- Therapy
- Biomarkers
- Diagnosis
- Survival Analysis
- Radiotherapy
- Breast Cancer
- Tumor Microenvironment
- Molecular Characterization
- Epidemiology
- Clinical Practice Guidelines
- Immunotherapy
- Chemotherapy
- Prognostic Factors
- Treatment
- Clinical Trials
- Metastasis
- Genetic Mutations
- Targeted Therapy
- Quality of Life
- Cancer
- Surgical Management
- Metastatic
- Precision Medicine
- Neoadjuvant Therapy
- Metastatic Breast Cancer
- Nephron-Sparing Surgery
- Immunohistochemistry
- Cetuximab
- PD-1 and PD-L1
- Genomic Profiling
- Molecular Subtypes
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy19▲ 22×20 topics
- Immunotherapy13▲ 15×16 topics
- Prognostic Factors12▲ 23×12 topics
- Clinical Practice Guidelines10▲ 15×9 topics
- Treatment9▲ 6.0×13 topics
- Epidemiology9▲ 1.76×34 topics
- Clinical Trials8▲ 9.9×5 topics
- Molecular Characterization8▲ 36×4 topics
- Metastasis7▲ 17×7 topics
- Tumor Microenvironment7▲ 13×7 topics
- Genetic Mutations7▲ 13×9 topics
- Breast Cancer7▲ 23×9 topics
- Targeted Therapy6▲ 23×5 topics
- Radiotherapy6▲ 13×10 topics
- Quality of Life6▲ 3.4×14 topics
- Survival Analysis6▲ 18×6 topics
- Cancer6▲ 3.6×24 topics
- Diagnosis6▲ 5.1×14 topics
- Surgical Management6▲ 11×7 topics
- Biomarkers5▲ 6.3×8 topics
- Metastatic5▲ 68×2 topics
- Therapy5▲ 21×4 topics
- Precision Medicine5▲ 8.5×4 topics
- Management5▲ 5.0×13 topics
- Neoadjuvant Therapy5▲ 17×5 topics
- Clinical Guidelines5▲ 13×4 topics
- Metastatic Breast Cancer5▲ 65×2 topics
- Survival4▲ 26×4 topics
- Nephron-Sparing Surgery4▲ 99×1 topic
- Renal Cell Carcinoma4▲ 99×1 topic
- Immunohistochemistry4▲ 45×3 topics
- Molecular Profiling4▲ 32×3 topics
- Cetuximab4▲ 36×2 topics
- Immune Checkpoint Blockade4▲ 28×1 topic
- PD-1 and PD-L14▲ 28×1 topic
- Adjuvant Therapy4▲ 22×2 topics
- Genomic Profiling4▲ 28×2 topics
- Ovarian Cancer4▲ 33×2 topics
- Molecular Subtypes3▲ 31×3 topics
- Hepatocellular Carcinoma3▲ 12×2 topics
Which research topics does Moscow City Oncology Hospital №62 publish most on?
By volume in 2022–2025: Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers, Cancer Diagnosis and Treatment and Hepatocellular Carcinoma Treatment and Prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 4 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 3 Cancer Diagnosis and Treatment Oncology 3 works
- 4 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 3 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
- 7 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
- 8 Colorectal Cancer Treatments and Studies Oncology 2 works
- 9 Cancer Treatment and Pharmacology Oncology 2 works
- 10 Multiple and Secondary Primary Cancers Epidemiology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Moscow City Oncology Hospital №62's research output changed?
Output in 2018–2022 was 146% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Moscow
- Russian Academy of Sciences
- Lomonosov Moscow State University
- National Research University Higher School of Economics
- Peoples' Friendship University of Russia
- Sechenov University
- Bauman Moscow State Technical University
- Kurchatov Institute
- N.D. Zelinsky Institute of Organic Chemistry
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.